Stuttgart - Delayed Quote EUR
Addex Therapeutics Ltd (APE1.SG)
6.25
+0.10
+(1.63%)
At close: April 17 at 11:10:33 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 3 |
| Avg. Estimate | 150k | 200k | 1.5M | 766.67k |
| Low Estimate | 150k | 200k | 1.5M | -- |
| High Estimate | 150k | 200k | 1.5M | 1.5M |
| Year Ago Sales | 153.45k | -- | 1.65M | 1.5M |
| Sales Growth (year/est) | -2.25% | -- | -8.93% | -48.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APE1.SG | -- | -- | -- | -- |
| S&P 500 | 7.05% | 4.85% | 8.57% | 14.16% |
Upgrades & Downgrades
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 7/31/2024 |
Related Tickers
IMR.F AC Immune SA
1.2560
+0.96%
OXB.L Oxford Biomedica plc
299.00
-1.64%
RLFTF Relief Therapeutics Holding SA
2.6700
-13.87%
ROIV Roivant Sciences Ltd.
10.04
-1.08%
RPRX Royalty Pharma plc
32.19
-1.26%
ONCO Onconetix, Inc.
0.0543
-8.74%
CVAC CureVac N.V.
3.2100
+2.88%
IBO Impact BioMedical Inc.
0.4197
+4.25%
KROS Keros Therapeutics, Inc.
14.30
+1.63%
HEPA Hepion Pharmaceuticals, Inc.
0.2700
-16.18%